Logo image of STSS

SHARPS TECHNOLOGY INC (STSS) Stock Price, Quote, News and Overview

NASDAQ:STSS - Nasdaq - US82003F2002 - Common Stock - Currency: USD

5.45  0 (0%)

After market: 5.3264 -0.12 (-2.27%)

STSS Quote, Performance and Key Statistics

SHARPS TECHNOLOGY INC

NASDAQ:STSS (6/30/2025, 8:00:01 PM)

After market: 5.3264 -0.12 (-2.27%)

5.45

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High2224.2
52 Week Low3.36
Market Cap5.56M
Shares1.02M
Float1.02M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO04-14 2022-04-14


STSS short term performance overview.The bars show the price performance of STSS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -50

STSS long term performance overview.The bars show the price performance of STSS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of STSS is 5.45 USD. In the past month the price increased by 45.33%. In the past year, price decreased by -99.68%.

SHARPS TECHNOLOGY INC / STSS Daily stock chart

STSS Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ALC ALCON INC 29.43 44.11B
COO COOPER COS INC/THE 18.34 14.23B
ALGN ALIGN TECHNOLOGY INC 20.29 13.72B
SOLV SOLVENTUM CORP 12.75 13.12B
LNTH LANTHEUS HOLDINGS INC 12.37 5.66B
MMSI MERIT MEDICAL SYSTEMS INC 26.18 5.52B
BLCO BAUSCH + LOMB CORP 27.1 4.60B
HAE HAEMONETICS CORP/MASS 16.33 3.58B
ICUI ICU MEDICAL INC 18.93 3.25B
XRAY DENTSPLY SIRONA INC 9.45 3.16B
UFPT UFP TECHNOLOGIES INC 29.88 1.88B
ESTA ESTABLISHMENT LABS HOLDINGS N/A 1.24B

About STSS

Company Profile

STSS logo image Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Company Info

SHARPS TECHNOLOGY INC

105 Maxess Road, Ste. 124

Melville NEW YORK US

Employees: 5

STSS Company Website

STSS Investor Relations

Phone: 15162464000

SHARPS TECHNOLOGY INC / STSS FAQ

What is the stock price of SHARPS TECHNOLOGY INC today?

The current stock price of STSS is 5.45 USD.


What is the ticker symbol for SHARPS TECHNOLOGY INC stock?

The exchange symbol of SHARPS TECHNOLOGY INC is STSS and it is listed on the Nasdaq exchange.


On which exchange is STSS stock listed?

STSS stock is listed on the Nasdaq exchange.


What is SHARPS TECHNOLOGY INC worth?

SHARPS TECHNOLOGY INC (STSS) has a market capitalization of 5.56M USD. This makes STSS a Nano Cap stock.


How many employees does SHARPS TECHNOLOGY INC have?

SHARPS TECHNOLOGY INC (STSS) currently has 5 employees.


What are the support and resistance levels for SHARPS TECHNOLOGY INC (STSS) stock?

SHARPS TECHNOLOGY INC (STSS) has a support level at 5.39 and a resistance level at 5.56. Check the full technical report for a detailed analysis of STSS support and resistance levels.


Should I buy SHARPS TECHNOLOGY INC (STSS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SHARPS TECHNOLOGY INC (STSS) stock pay dividends?

STSS does not pay a dividend.


What is the Price/Earnings (PE) ratio of SHARPS TECHNOLOGY INC (STSS)?

SHARPS TECHNOLOGY INC (STSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2100.47).


What is the Short Interest ratio of SHARPS TECHNOLOGY INC (STSS) stock?

The outstanding short interest for SHARPS TECHNOLOGY INC (STSS) is 11.45% of its float. Check the ownership tab for more information on the STSS short interest.


STSS Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to STSS. When comparing the yearly performance of all stocks, STSS is a bad performer in the overall market: 98.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

STSS Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to STSS. Both the profitability and financial health of STSS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

STSS Financial Highlights

Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -2100.47. The EPS increased by 58.48% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -127.1%
ROE -465.72%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%36.42%
Sales Q2Q%N/A
EPS 1Y (TTM)58.48%
Revenue 1Y (TTM)N/A

STSS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to STSS. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners6.14%
Ins Owners0.06%
Short Float %11.45%
Short Ratio0
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A